Chemical biology approaches to target validation in cancer

Julian Blagg1, Paul Workman1

  • 1Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, UK.

Insights

Robust target validation in drug discovery requires integrating complementary biological and chemical biology methods. This approach enhances confidence in potential cancer targets, especially those previously considered undruggable.

Area of Science:

  • Oncology
  • Drug Discovery
  • Chemical Biology

Background:

  • Target validation is critical in drug discovery due to extensive genomic data and high downstream costs.
  • Identifying reliable cancer targets is essential before significant investment in drug development.

Purpose of the Study:

  • To emphasize the necessity of robust target validation strategies in cancer drug discovery.
  • To highlight the role of chemical biology tools in validating challenging cancer targets.

Main Methods:

  • Reviewing recent advancements in chemical biology tools for target validation.
  • Discussing the application of high-quality chemical probes and chemical biology approaches.
  • Examining the use of designed irreversible chemical tools.

Main Results:

  • Complementary biological and chemical biology strategies provide robust target validation.
  • Chemical biology offers effective methods for validating previously undruggable targets.
  • Irreversible chemical tools are emerging as powerful agents for target and pathway interrogation.

Conclusions:

  • Integrating diverse methodologies is key for successful target validation in oncology.
  • Chemical biology significantly contributes to overcoming challenges in validating difficult cancer targets.
  • Advanced chemical tools enable deeper understanding and exploitation of oncogenic pathways.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
117
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.2K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.0K